Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-06 Sale | 2024-03-08 4:36 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,086 | $12.31 | $50,285 | 74,170 (Direct) | View |
| 2023-12-21 Sale | 2023-12-26 4:35 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 12,500 | $15.59 | $194,845 | 216,436 (Direct) | View |
| 2023-09-06 Sale | 2023-09-06 5:11 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 950 | $13.48 | $12,806 | 71,071 (Direct) | View |
| 2023-07-10 Sale | 2023-07-12 4:34 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 10,000 | $17.99 | $179,862 | 169,945 (Direct) | View |
| 2023-06-21 Sale | 2023-06-23 4:20 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 17,500 | $15.01 | $262,648 | 111,404 (Direct) | View |
| 2023-03-02 Sale | 2023-03-03 4:37 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,747 | $10.53 | $18,389 | 85,157 (Direct) | View |
| 2022-12-08 Sale | 2022-12-12 4:36 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,550 | $18.95 | $86,238 | 117,456 (Direct) | View |
| 2022-12-02 Sale | 2022-12-06 5:02 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 3,110 | $18.19 | $56,559 | 227,703 (Direct) | View |
| 2022-11-16 Sale | 2022-11-18 4:59 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 200 | $18.1 | $3,620 | 125,116 (Direct) | View |
| 2022-08-24 Sale | 2022-08-26 4:06 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,669 | $13.78 | $64,362 | 119,793 (Direct) | View |
| 2022-08-19 Sale | 2022-08-23 6:28 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 11,655 | $13.08 | $152,432 | 347,233 (Direct) | View |
| 2022-08-16 Sale | 2022-08-18 6:53 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 600 | $13.02 | $7,814 | 368,209 (Direct) | View |
| 2020-08-03 Sale | 2020-08-05 4:06 pm | bluebird bio Inc. | BLUE | WENTWORTH KORY JAMES Principal Accounting Officer | 82 | $61 | $5,002 | 9,512 (Direct) | View |
| 2020-07-20 Sale | 2020-07-22 5:22 pm | bluebird bio Inc. | BLUE | WENTWORTH KORY JAMES Principal Accounting Officer | 596 | $66.38 | $39,562 | 9,594 (Direct) | View |
| 2020-06-04 Sale | 2020-06-08 4:24 pm | bluebird bio Inc. | BLUE | WENTWORTH KORY JAMES Principal Accounting Officer | 154 | $65.23 | $10,045 | 10,190 (Direct) | View |
| 2020-01-07 Sale | 2020-01-09 5:33 pm | bluebird bio Inc. | BLUE | WENTWORTH KORY JAMES Principal Accounting Officer | 223 | $89.97 | $20,064 | 6,308 (Direct) | View |
| 2019-12-19 Sale | 2019-12-23 5:00 pm | bluebird bio Inc. | BLUE | WENTWORTH KORY JAMES Principal Accounting Officer | 397 | $92.59 | $36,758 | 6,449 (Direct) | View |
| 2019-06-05 Sale | 2019-06-07 4:11 pm | bluebird bio Inc. | BLUE | WENTWORTH KORY JAMES Principal Accounting Officer | 61 | $127.6 | $7,784 | 6,846 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-15 Exercise | 2024-03-19 4:33 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 9,000 | $0 | 126,327 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-19 4:33 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 9,000 | $2.1 | 126,327 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:47 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 77,700 | $0 | 125,056 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 339 | $12.42 | 125,056 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 405 | $13.37 | 125,056 (Direct) | View |
| 2024-03-05 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,471 | $12.28 | 125,056 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-26 4:35 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 12,500 | $0 | 216,436 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-26 4:35 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 12,500 | $2.1 | 216,436 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-06 5:11 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 35,700 | $0 | 71,071 (Direct) | View |
| 2023-09-05 Tax Withholding | 2023-09-06 5:11 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 426 | $14.46 | 71,071 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-12 4:34 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 10,000 | $0 | 169,945 (Direct) | View |
| 2023-07-10 Exercise | 2023-07-12 4:34 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 10,000 | $2.1 | 169,945 (Direct) | View |
| 2023-06-29 Exercise | 2023-06-30 4:32 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 8,790 | $0 | 111,404 (Direct) | View |
| 2023-06-29 Exercise | 2023-06-30 4:32 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 8,790 | $2.1 | 111,404 (Direct) | View |
| 2023-06-21 Exercise | 2023-06-23 4:20 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 17,500 | $0 | 111,404 (Direct) | View |
| 2023-06-21 Exercise | 2023-06-23 4:20 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 17,500 | $2.1 | 111,404 (Direct) | View |
| 2023-03-01 Option Award(A) | 2023-04-19 5:49 pm | N/A 2033-03-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 35,700 | $0 | 49,457 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:37 pm | N/A 2033-03-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 71,400 | $0 | 85,157 (Direct) | View |
| 2023-03-02 Tax Withholding | 2023-03-03 4:37 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,005 | $11.6 | 85,157 (Direct) | View |
| 2022-12-08 Exercise | 2022-12-12 4:36 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,550 | $0 | 117,456 (Direct) | View |
| 2022-12-08 Exercise | 2022-12-12 4:36 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,550 | $2.1 | 117,456 (Direct) | View |
| 2022-12-02 Exercise | 2022-12-06 5:02 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 3,110 | $0 | 227,703 (Direct) | View |
| 2022-12-02 Exercise | 2022-12-06 5:02 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 3,110 | $2.1 | 227,703 (Direct) | View |
| 2022-11-16 Exercise | 2022-11-18 4:59 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 200 | $0 | 125,116 (Direct) | View |
| 2022-11-16 Exercise | 2022-11-18 4:59 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 200 | $2.1 | 125,116 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:34 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 5,503 | $0 | 16,489 (Direct) | View |
| 2022-08-24 Exercise | 2022-08-26 4:06 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,117 | $0 | 119,793 (Direct) | View |
| 2022-08-24 Exercise | 2022-08-26 4:06 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,117 | $2.1 | 119,793 (Direct) | View |
| 2022-08-19 Exercise | 2022-08-23 6:28 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 5,972 | $0 | 347,233 (Direct) | View |
| 2022-08-19 Exercise | 2022-08-23 6:28 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 5,972 | $2.1 | 347,233 (Direct) | View |
| 2022-08-16 Exercise | 2022-08-18 6:53 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 300 | $0 | 368,209 (Direct) | View |
| 2022-08-16 Exercise | 2022-08-18 6:53 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 300 | $2.1 | 368,209 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:20 pm | N/A 2032-07-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 33,019 | $0 | 33,019 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:09 pm | N/A 2032-03-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 77,044 | $0 | 86,579 (Direct) | View |
| 2021-10-28 Option Award | 2021-11-01 7:03 pm | N/A 2031-10-28 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 72,012 | $0 | 72,012 (Direct) | View |
Ownership | 2021-10-28 8:52 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 0 | $0 | 211,746 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:19 pm | N/A 2030-03-02 | bluebird bio Inc. | BLUE | WENTWORTH KORY JAMES Principal Accounting Officer | 11,700 | $0 | 18,144 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-05 5:06 pm | N/A N/A | bluebird bio Inc. | BLUE | WENTWORTH KORY JAMES Principal Accounting Officer | 212 | $0 | 6,907 (Direct) | View |